DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award
- · 7d
- Not stated
- 6
- Jun 17, 2026
Official announcement on grants_gov · opens the funder's page. Always confirm dates there.
Summary
The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. […]
The rest of this announcement — free with an account
- The full announcement text, not the first two sentences
- The review-criteria section of this announcement, extracted in full
- Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- What similar funded projects received, from 219,000 past awards
More from Defense Health Agency Contracting Activity - DHACA
More in musculoskeletal
DoW Duchenne Muscular Dystrophy, Idea Development Award
HEAL INITIATIVE: INTERACT Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)
Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed)
$500k